Skip to main content
RUBICON RESEARCH LIMITED logo

RUBICON RESEARCH LIMITED — Investor Relations & Filings

Ticker · RUBICON ISIN · INE506V01022 LEI · 335800GME6PCQIKP8T34 BSE.NS Manufacturing
Open in API
Filings indexed 116 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS RUBICON

About RUBICON RESEARCH LIMITED

https://www.rubicon.co.in/

Rubicon Research Limited is a specialty organization focused on formulation development and the commercialization of value-added products. The company leverages proprietary drug delivery technology platforms to develop complex oral solids, liquids, topicals, and sterile dosage forms. Its core business activities encompass contract research and manufacturing services alongside the development of a diverse portfolio of Abbreviated New Drug Applications. The firm operates advanced research and development centers and manufacturing facilities that comply with stringent international regulatory standards. Rubicon Research emphasizes innovation in life cycle management and the enhancement of existing molecules to improve patient compliance and therapeutic outcomes. Its operations provide end-to-end solutions from initial concept and formulation design to commercial-scale production, serving global markets with a focus on high-quality, technology-driven solutions.

Recent filings

Filing Released Lang Actions
Earnings Call Audio Recording
Regulatory Filings Classification · 75% confidence The document is a notification filed under SEBI Listing Regulations to India’s stock exchanges announcing that the audio recording of the earnings conference call is available on the company website. It contains no financial highlights, transcript text, or substantive report data. It is neither an earnings release (ER) nor a call transcript (CT) but a routine regulatory disclosure. Therefore, it falls into the fallback category of general regulatory filings (RNS).
2026-05-30 English
Rubicon Newspaper Publication under reg 30
Regulatory Filings Classification · 90% confidence The document is a compliance letter under SEBI (LODR) Regulation 47 to BSE & NSE enclosing newspaper advertisements of the Audited Standalone & Consolidated Financial Results for the quarter and year ended March 31, 2026. It does not itself contain substantive financial statements (so is not an interim report) nor a full earnings release with highlights; instead it is a regulatory announcement to the stock exchanges. This falls under “Regulatory Filings” (fallback) rather than ER, IR, or RPA.
2026-05-30 English
Updates
Regulatory Filings Classification · 85% confidence The document is a short stock exchange filing notifying BSE and NSE that the audio recording of the earnings conference call for the quarter and financial year ended March 31, 2026 is available online. It contains no financial data or results, no presentation materials, and no management discussion. It is simply a regulatory announcement under SEBI LODR. This best fits the general Regulatory Filings category (RNS).
2026-05-30 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 82% confidence The document is a brief compliance letter to stock exchanges under SEBI LODR Regulation 47 notifying them that the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 have been published in newspapers and are available on the company website. It contains no substantive financial data itself and simply announces the publication of a report. Thus it is an announcement of a report’s publication, not the report itself. This matches the definition of Report Publication Announcement (RPA).
2026-05-30 English
Updates
Share Issue/Capital Change Classification · 95% confidence The document is a formal stock exchange filing under SEBI Listing Regulations disclosing the allotment of fully paid-up equity shares pursuant to employee stock option exercise and the resultant increase in issued and paid-up share capital. This is a direct announcement of a share issue/capital change rather than a broader report or meeting material. Therefore, it fits the Share Issue/Capital Change category (SHA).
2026-05-29 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (SEBI Listing Regulations)
Share Issue/Capital Change Classification · 91% confidence The document is an exchange intimation under SEBI Listing Regulations notifying the allotment of 290,626 equity shares upon exercise of employee stock options and the consequent increase in paid-up share capital. This is a direct announcement of a share issuance/capital change, matching the definition of Share Issue/Capital Change (Code: SHA).
2026-05-29 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.